Two Sigma Investments, LP Cue Biopharma, Inc. Transaction History

Two Sigma Investments, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.77 - $3.09 $35,353 - $61,719	19,974 New	19,974 $37,000
Q2 2023 Aug 14, 2023	BUY	$3.11 - $4.91 $43,776 - $69,113	14,076 New	14,076 $51,000
Q3 2022 Nov 14, 2022	SELL	$2.23 - $3.37 $215,756 - $326,054	-96,752 Reduced 73.94%	34,102 $76,000
Q2 2022 Aug 15, 2022	SELL	$2.49 - $5.92 $114,295 - $271,739	-45,902 Reduced 25.97%	130,854 $326,000
Q1 2022 May 16, 2022	BUY	$4.41 - $12.28 $533,636 - $1.49 Million	121,006 Added 217.05%	176,756 $863,000
Q4 2021 Feb 14, 2022	SELL	$10.86 - $17.85 $517,804 - $851,088	-47,680 Reduced 46.1%	55,750 $631,000
Q3 2021 Nov 15, 2021	SELL	$10.06 - $15.3 $980,226 - $1.49 Million	-97,438 Reduced 48.51%	103,430 $1.51 Million
Q2 2021 Aug 16, 2021	SELL	$10.9 - $14.53 $1.34 Million - $1.79 Million	-123,090 Reduced 38.0%	200,868 $2.34 Million
Q1 2021 May 17, 2021	SELL	$11.2 - $16.09 $11,670 - $16,765	-1,042 Reduced 0.32%	323,958 $3.95 Million
Q4 2020 Feb 16, 2021	BUY	$11.12 - $16.4 $280,034 - $413,001	25,183 Added 8.4%	325,000 $4.07 Million
Q3 2020 Nov 16, 2020	BUY	$15.05 - $23.54 $998,808 - $1.56 Million	66,366 Added 28.43%	299,817 $4.51 Million
Q2 2020 Aug 14, 2020	BUY	$12.7 - $30.73 $2.96 Million - $7.17 Million	233,451 New	233,451 $5.72 Million

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $38.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.